PL367097A1 - Method of treating dry eye disorders - Google Patents
Method of treating dry eye disordersInfo
- Publication number
- PL367097A1 PL367097A1 PL02367097A PL36709702A PL367097A1 PL 367097 A1 PL367097 A1 PL 367097A1 PL 02367097 A PL02367097 A PL 02367097A PL 36709702 A PL36709702 A PL 36709702A PL 367097 A1 PL367097 A1 PL 367097A1
- Authority
- PL
- Poland
- Prior art keywords
- dry eye
- eye disorders
- treating dry
- treating
- disorders
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29250001P | 2001-05-21 | 2001-05-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
PL367097A1 true PL367097A1 (en) | 2005-02-21 |
Family
ID=23124938
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL02367097A PL367097A1 (en) | 2001-05-21 | 2002-05-17 | Method of treating dry eye disorders |
Country Status (10)
Country | Link |
---|---|
US (1) | US20030008853A1 (xx) |
EP (1) | EP1392322A1 (xx) |
JP (1) | JP2004531560A (xx) |
CN (1) | CN1239161C (xx) |
BR (1) | BR0209882A (xx) |
CA (1) | CA2447918A1 (xx) |
MX (1) | MXPA03010633A (xx) |
PL (1) | PL367097A1 (xx) |
WO (1) | WO2002094284A1 (xx) |
ZA (1) | ZA200308770B (xx) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005094836A2 (en) | 2004-03-25 | 2005-10-13 | Bausch & Lomb Incorporated | Use of loteprednol etabonate for the treatment of dry eye |
WO2007137129A2 (en) * | 2006-05-19 | 2007-11-29 | Alcon Research, Ltd. | RNAI-MEDIATED INHIBITION OF TUMOR NECROSIS FACTOR α-RELATED CONDITIONS |
US7691811B2 (en) * | 2006-05-25 | 2010-04-06 | Bodor Nicholas S | Transporter-enhanced corticosteroid activity and methods and compositions for treating dry eye |
Family Cites Families (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US527851A (en) * | 1894-10-23 | Process of reducing aluminium | ||
US3991759A (en) * | 1975-10-28 | 1976-11-16 | Alza Corporation | Method and therapeutic system for treating aqueous deficient dry eye |
US4131651A (en) * | 1977-10-25 | 1978-12-26 | Barnes-Hind Pharmaceuticals, Inc. | Treatment of dry eye |
US4409205A (en) * | 1979-03-05 | 1983-10-11 | Cooper Laboratories, Inc. | Ophthalmic solution |
US4370325A (en) * | 1979-03-30 | 1983-01-25 | Dermik Laboratories | Pharmaceutical compositions and method of treatment |
US4883658A (en) * | 1986-04-28 | 1989-11-28 | Holly Frank J | Ophthalmic solution for treatment of dry-eye syndrome |
US4744980A (en) * | 1986-04-28 | 1988-05-17 | Holly Frank J | Ophthalmic solution for treatment of dry eye syndrome |
US4804539A (en) * | 1986-07-28 | 1989-02-14 | Liposome Technology, Inc. | Ophthalmic liposomes |
US4818537A (en) * | 1986-10-21 | 1989-04-04 | Liposome Technology, Inc. | Liposome composition for treating dry eye |
US4966773A (en) * | 1986-11-25 | 1990-10-30 | Alcon Laboratories, Inc. | Topical ophthalmic compositions containing microfine retinoid particles |
US4914088A (en) * | 1987-04-02 | 1990-04-03 | Thomas Glonek | Dry eye treatment solution and method |
US5075104A (en) * | 1989-03-31 | 1991-12-24 | Alcon Laboratories, Inc. | Ophthalmic carboxy vinyl polymer gel for dry eye syndrome |
US5174988A (en) * | 1989-07-27 | 1992-12-29 | Scientific Development & Research, Inc. | Phospholipid delivery system |
US5583150A (en) * | 1989-08-18 | 1996-12-10 | Alcon Laboratories, Inc. | 5-methyl-isoxazole-4-carboxylic acid anilides and 2-hydroxyethylidene-cyano acetic anilides for the treatment of ocular diseases |
US5041434A (en) * | 1991-08-17 | 1991-08-20 | Virginia Lubkin | Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application |
ZA912797B (en) * | 1990-05-29 | 1992-12-30 | Boston Ocular Res | Dry eye treatment process and solution |
ATE132366T1 (de) * | 1990-05-29 | 1996-01-15 | Boston Ocular Res | Zusammensetzung zur behandlung von dry eye erkrankungen |
ATE141502T1 (de) * | 1991-01-15 | 1996-09-15 | Alcon Lab Inc | Verwendung von karrageenan in topischen ophthalmologischen zusammensetzungen |
US6107289A (en) * | 1992-04-21 | 2000-08-22 | The Schepens Eye Research Institute, Inc. | Ocular therapy in keratoconjunctivitis sicca using topically applied androgens or TGF-β |
US5958912A (en) * | 1992-04-21 | 1999-09-28 | The Schepens Eye Research Institute, Inc. | Ocular therapy in keratoconjunctivitis sicca using topically applied androgens of TGF-β |
CA2133966C (en) * | 1992-04-21 | 1997-09-09 | David A. Sullivan | Ocular androgen therapy in sjogren's syndrome |
US5506221A (en) * | 1992-12-24 | 1996-04-09 | University Of British Columbia | Contignasterol, and related 3-alpha hydroxy-6-alpha hydroxy-7-beta hydroxy-15-keto-14-beta steroids useful as anti-inflammatory and anti-thrombosis agents |
US5696166A (en) * | 1995-10-31 | 1997-12-09 | Yanni; John M. | Compositions containing hydroxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders |
WO1997020578A1 (en) * | 1995-12-04 | 1997-06-12 | University Of Miami | Non-preserved topical corticosteroid for treatment of dry eye, filamentary keratitis, and delayed tear clearance |
US6046185A (en) * | 1996-07-11 | 2000-04-04 | Inflazyme Pharmaceuticals Ltd. | 6,7-oxygenated steroids and uses related thereto |
US6071904A (en) * | 1996-12-11 | 2000-06-06 | Alcon Laboratories, Inc. | Process for manufacturing ophthalmic suspensions |
US5800807A (en) * | 1997-01-29 | 1998-09-01 | Bausch & Lomb Incorporated | Ophthalmic compositions including glycerin and propylene glycol |
AU2792997A (en) * | 1997-05-26 | 1998-12-30 | New Vision Co., Ltd. | Medicinal compositions for topical administration containing vitamin d and vitamin k |
US6096733A (en) * | 1998-12-10 | 2000-08-01 | Virginia Lubkin | Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application |
EP1379540A4 (en) * | 2001-04-19 | 2005-11-16 | Bristol Myers Squibb Co | POLYNUCLEOTIDES AND POLYPEPTIDES ASSOCIATED WITH NF-KB PATH |
US20040076691A1 (en) * | 2002-01-16 | 2004-04-22 | David Haines | Anti-inflammatory formulations |
-
2002
- 2002-05-17 EP EP02746411A patent/EP1392322A1/en not_active Withdrawn
- 2002-05-17 WO PCT/US2002/015784 patent/WO2002094284A1/en not_active Application Discontinuation
- 2002-05-17 CN CNB028102428A patent/CN1239161C/zh not_active Expired - Fee Related
- 2002-05-17 CA CA002447918A patent/CA2447918A1/en not_active Abandoned
- 2002-05-17 BR BR0209882-2A patent/BR0209882A/pt not_active IP Right Cessation
- 2002-05-17 US US10/150,199 patent/US20030008853A1/en not_active Abandoned
- 2002-05-17 PL PL02367097A patent/PL367097A1/xx unknown
- 2002-05-17 JP JP2002591001A patent/JP2004531560A/ja active Pending
-
2003
- 2003-11-11 ZA ZA200308770A patent/ZA200308770B/en unknown
- 2003-11-19 MX MXPA03010633A patent/MXPA03010633A/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CN1239161C (zh) | 2006-02-01 |
CA2447918A1 (en) | 2002-11-28 |
EP1392322A1 (en) | 2004-03-03 |
US20030008853A1 (en) | 2003-01-09 |
CN1509177A (zh) | 2004-06-30 |
WO2002094284A1 (en) | 2002-11-28 |
BR0209882A (pt) | 2004-06-08 |
JP2004531560A (ja) | 2004-10-14 |
MXPA03010633A (es) | 2004-03-09 |
ZA200308770B (en) | 2004-11-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1068778A1 (en) | Insert for the treatment of dry eye | |
EP1328186A4 (en) | METHODS OF TREATING VARIOUS EYES DISEASES | |
GB2393202B (en) | Methods of well treatment | |
GB0007193D0 (en) | Treatment of movrmrnt disorders | |
AU7316601A (en) | Methods for treating inflammation-mediated conditions of the eye | |
GB0014969D0 (en) | Novel method of treatment | |
AU2003239489A8 (en) | Method of treating dyslipidemic disorders | |
EP1393708A4 (en) | HAIR PROCESSING PROCESS | |
EP1414464A4 (en) | METHOD OF TREATING GLAUCOMA | |
GB0109087D0 (en) | Treatment of suspensions | |
EP1476147A4 (en) | METHODS OF TREATING VIEW DISORDERS | |
PL368556A1 (en) | Methods for treating or preventing skin disorders using cd2-binding agents | |
PL368935A1 (en) | Methods of treating pulmonary disease | |
AU2002365814A8 (en) | Method of treating asthma | |
AU8333701A (en) | Method of treating angiogenesis-related disorders | |
EP1389105A4 (en) | METHOD OF TREATMENT | |
GB0124124D0 (en) | Methods of treatment | |
AU2001288792A1 (en) | Method of treating neurologic disorders | |
GB0112216D0 (en) | Method of treatment | |
IL162053A0 (en) | Method for the treatment of bone disorders | |
PL367097A1 (en) | Method of treating dry eye disorders | |
GB0118892D0 (en) | Method of treatment | |
EP1389129A4 (en) | METHOD FOR TREATING RESPIRATORY DISEASES | |
GB0008921D0 (en) | Method of treatment | |
GB0203060D0 (en) | Method of treating hair loss |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
DISC | Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications) |